Initial endomysial antibody testing for diagnosis of coeliac disease is the least costly strategy in a low-risk population;

Author：

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.347, 2002-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Failure of initial antibacterial therapy costly

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 492, 2005-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Coeliac disease. From A – Z

By Haboubi Nadim Jones Sian

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 7, 2007-07 ,pp. : 799-817

Informa Healthcare

Access to resources Recommend Favorite

Recent advances in coeliac disease

By Ciclitira Paul J

Clinical Medicine, Vol. 3, Iss. 2, 2003-03 ,pp. : 166-169

Royal College Of Physicians

Access to resources Recommend Favorite

Discrepancies between histology and serology for the diagnosis of coeliac disease in a district general hospital: is this an unrecognised problem in other hospitals?

By Sweis Rami Pee Leon Smith-Laing Gray

Clinical Medicine, Vol. 9, Iss. 4, 2009-08 ,pp. : 346-348

Royal College Of Physicians

Access to resources Recommend Favorite

Medical management least costly option in phimosis

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 307, 2001-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite